MACC1 and metastatic malignant neoplasm in the lymph nodes: Univariate analysis showed that patients with lymph node metastasis (p=0.008), advanced TNM stage (p<0.001), high YB-1 expression (p=0.004) and high MACC1 expression (p=0.044) had poorer survival outcomes (Table 3).